Loading…

Antibiotic susceptibility and molecular epidemiology of Panton–Valentine leukocidin-positive meticillin-resistant Staphylococcus aureus: An international survey

The antibiotic susceptibility and molecular epidemiology of Panton–Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) isolates reported from 17 countries in the Americas, Europe and, Australia-Asia were analysed. Among a total of 3236 non-duplicate isolates, the lo...

Full description

Saved in:
Bibliographic Details
Published in:Journal of global antimicrobial resistance. 2014-03, Vol.2 (1), p.43-47
Main Authors: Macedo-Viñas, Marina, Conly, John, Francois, Patrice, Aschbacher, Richard, Blanc, Dominique S., Coombs, Geoffrey, Daikos, George, Dhawan, Benu, Empel, Joanna, Etienne, Jerome, Figueiredo, Agnes Marie Sá, George Golding & CNISP, Han, Lizhong, Kim, Hong Bin, Köck, Robin, Larsen, Anders, Layer, Franziska, Lo, Janice, Maeda, Tadashi, Mulvey, Michael, Pantosti, Annalisa, Saga, Tomoo, Schrenzel, Jacques, Simor, Andrew, Skov, Robert, Van Rijen, Miranda, Wang, Hui, Zakaria, Zunita, Harbarth, Stephan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The antibiotic susceptibility and molecular epidemiology of Panton–Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) isolates reported from 17 countries in the Americas, Europe and, Australia-Asia were analysed. Among a total of 3236 non-duplicate isolates, the lowest susceptibility was observed to erythromycin in all regions. Susceptibility to ciprofloxacin showed large variation (25%, 75% and 84% in the Americas, Europe and Australia-Asia, respectively). Two vancomycin-intermediate PVL-positive MRSA isolates were reported, one from Hong Kong and the other from The Netherlands. Resistance to trimethoprim/sulfamethoxazole and linezolid was
ISSN:2213-7165
2213-7173
DOI:10.1016/j.jgar.2013.08.003